MAGNETAR CAPITAL
Magnetar is a leading alternative asset manager. Magnetar endeavors to source its own, often unique, investment opportunities by collaborating across distinct areas of expertise. Headquartered in Evanston, Illinois, Magnetar has satellite and affiliate offices in New York, Philadelphia, London, and Beijing. Investment advisory services are provided through Magnetar Financial LLC, which is registered as an investment adviser with the SEC.
MAGNETAR CAPITAL
Social Links:
Industry:
Asset Management Financial Services Hedge Funds Wealth Management
Founded:
2005-04-01
Status:
Active
Contact:
212 993 1640
Technology used in webpage:
Domain Not Resolving Euro Google Maps Apple Whitelist Citrix NetScaler
Similar Organizations
50 South Capital
50 South Capital a global alternatives firm that provides access to the private equity and hedge fund investment opportunities.
Alpha Wave Global
Alpha Wave Global provides asset classes, themes, and geographies from venture capital to public markets to credit.
NIO Capital
NIO Capital is a fund manager investing in themes reshaping the automotive, new energy and technology sectors.
Bain Capital Credit
Bain Capital Credit, formerly Sankaty Advisors, is one of the nation's leading private managers of fixed income and credit
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-27 | Enable Injections | Magnetar Capital investment in Series C - Enable Injections | 215 M USD |
| 2022-01-05 | PosiGen | Magnetar Capital investment in Private Equity Round - PosiGen | 100 M USD |
| 2021-11-10 | CoreWeave | Magnetar Capital investment in Private Equity Round - CoreWeave | 50 M USD |
| 2021-10-18 | Comtech Telecommunications | Magnetar Capital investment in Post-IPO Equity - Comtech Telecommunications | 100 M USD |
| 2021-09-30 | Activ Surgical | Magnetar Capital investment in Series B - Activ Surgical | 45 M USD |
| 2021-07-21 | Vedanta Biosciences | Magnetar Capital investment in Series D - Vedanta Biosciences | 43 M USD |
| 2021-07-19 | Evolv Technology | Magnetar Capital investment in Post-IPO Equity - Evolv Technology | 300 M USD |
| 2021-03-31 | OncoResponse | Magnetar Capital investment in Series C - OncoResponse | 40.6 M USD |
| 2020-12-23 | Judo Bank | Magnetar Capital investment in Series D - Judo Bank | 284 M AUD |
| 2020-07-16 | Imvax | Magnetar Capital investment in Series C - Imvax | 112 M USD |